Elanco Animal Health (ELAN) Acquisitions (2019 - 2024)

Elanco Animal Health (ELAN) posted Acquisitions of $36.0 million for Q4 2024, up 620.0% sequentially from $5.0 million in Q1 2024.

Elanco Animal Health (ELAN) Acquisitions (2019 - 2024) Analysis & Trends

Elanco Animal Health has reported Acquisitions for 5 years, with the latest figure at $36.0 million in Q4 2024.

Quarterly Acquisitions changed N/A year-over-year to $36.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $41.0 million (up 115.79% YoY) and the FY2024 annual result came in at $41.0 million, up 115.79% from the prior year.
Acquisitions improved to $36.0 million in Q4 2024 per ELAN's latest filing, from $5.0 million in the prior quarter.
Over five years, Acquisitions peaked at $5.0 billion in Q3 2020 and troughed at -$73.0 million in Q1 2021.
A 4-year average of $771.9 million and a median of $16.0 million in 2023 frame the typical range for Acquisitions.
The sharpest annual moves came in 2021 and 2024: Acquisitions sank 91.7% in 2021, then sank 68.75% in 2024.
Over 4 years, Acquisitions stood at $5.0 billion in 2020, then tumbled by 91.7% to $415.0 million in 2021, then tumbled by 99.28% to $3.0 million in 2023, then soared by 1100.0% to $36.0 million in 2024.
According to Business Quant data, Acquisitions over the past three periods registered $36.0 million, $5.0 million, and $3.0 million for Q4 2024, Q1 2024, and Q3 2023 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-	-
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn	-
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn	-
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn	-
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn	-
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn	-
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-	-
10	Alkermes	8.02 Bn	7.37 Bn	397.90 Mn	-

Download Data